These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 12552372

  • 21. Small bowel hydro-MR imaging for optimized ileocecal distension in Crohn's disease: should an additional rectal enema filling be performed?
    Ajaj W, Lauenstein TC, Langhorst J, Kuehle C, Goyen M, Zoepf T, Ruehm SG, Gerken G, Debatin JF, Goehde SC.
    J Magn Reson Imaging; 2005 Jul; 22(1):92-100. PubMed ID: 15971189
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease.
    Stringer EE, Nicholson TJ, Armstrong D.
    Dis Colon Rectum; 2005 May; 48(5):970-4. PubMed ID: 15785894
    [Abstract] [Full Text] [Related]

  • 23. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 24. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
    Chrissafidou A, Malek M, Musch E.
    Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
    [Abstract] [Full Text] [Related]

  • 25. Predictive factors of azathioprine prescription in adult patients with Crohn's disease.
    Karoui S, Bibani N, Serghini M, Kallel L, Ben Mustapha N, Boubaker J, Filali A.
    Hepatogastroenterology; 2010 Jul; 57(98):283-7. PubMed ID: 20583428
    [Abstract] [Full Text] [Related]

  • 26. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 28. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study).
    Henriksen M, Jahnsen J, Lygren I, Aadland E, Schulz T, Vatn MH, Moum B, Ibsen Study Group.
    Scand J Gastroenterol; 2007 May; 42(5):602-10. PubMed ID: 17454881
    [Abstract] [Full Text] [Related]

  • 29. Magnetic resonance imaging of the small bowel in Crohn's disease.
    Frøkjaer JB, Larsen E, Steffensen E, Nielsen AH, Drewes AM.
    Scand J Gastroenterol; 2005 Jul; 40(7):832-42. PubMed ID: 16109660
    [Abstract] [Full Text] [Related]

  • 30. Drug safety in Crohn's disease therapy.
    Juillerat P, Pittet V, Felley C, Mottet C, Froehlich F, Vader JP, Gonvers JJ, Michetti P.
    Digestion; 2007 Jul; 76(2):161-8. PubMed ID: 18239408
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 33. Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.
    Pinto AL, Chebli LA, Ribeiro MS, Pace FH, Moraes JP, do Amaral FJ, Gaburri PD, Meirelles de Souza AF, Chebli JM.
    Med Sci Monit; 2009 May 01; 15(5):PI19-26. PubMed ID: 19396048
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD.
    Dis Colon Rectum; 2006 Dec 01; 49(12):1837-41. PubMed ID: 17041753
    [Abstract] [Full Text] [Related]

  • 36. [Duodenal Crohn's disease: diagnostic and therapeutic complexity].
    Sanjuán Portugal F, Cabrera Chaves T, Yus Gotor C, Gomollón García F.
    Gastroenterol Hepatol; 1998 Apr 01; 21(4):181-3. PubMed ID: 9633178
    [Abstract] [Full Text] [Related]

  • 37. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
    Borody TJ, Bilkey S, Wettstein AR, Leis S, Pang G, Tye S.
    Dig Liver Dis; 2007 May 01; 39(5):438-44. PubMed ID: 17369114
    [Abstract] [Full Text] [Related]

  • 38. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C, Festa V, Leandro G, Moretti A, Tanga M, Koch M, Capurso L.
    Am J Gastroenterol; 2007 Apr 01; 102(4):814-9. PubMed ID: 17222316
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Medical therapy to reduce postoperative Crohn's disease recurrence.
    Achkar JP, Hanauer SB.
    Am J Gastroenterol; 2000 May 01; 95(5):1139-46. PubMed ID: 10811318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.